Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

During the Trading Day
1.41 +0.07 / +5.22%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
1.43 +0.02 / +1.42%
Volume: 20.3K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Revenue and IncomeNet Revenues13.5M15.2M21.7M22.4M
Cost of Goods Sold6.6M9.2M11.5M12.1M
Depreciation And Amortization652.0K908.0K1.1M986.0K
Operating ExpensesGross Income6.2M5.1M9.1M9.3M
General Expenses40.9M47.2M37.4M45.0M
Research And Development29.5M35.7M24.3M27.7M
Total Operating Expenses48.2M57.3M50.0M58.1M
Non-Operating ExpensesOperating Income-34.7M-42.1M-28.4M-35.7M
Extraordinary Charge0.000.00-1.7M0.00
Interest Expense On Debt516.0K90.0K54.0K5.0K
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-34.2M-42.1M-29.8M-35.4M
Preferred Dividend0.000.000.00-401.0K
Net Income-34.2M-42.1M-29.8M-35.4M
Shares To Calculate EPSShares To Calculate EPS60.9M83.6M120.4M161.6M
Shares To Calculate EPS Diluted60.9M83.6M120.4M161.6M
Earnings Per ShareEPS-$0.56-$0.50-$0.25-$0.22
EPS Diluted-$0.56-$0.50-$0.25-$0.22

To view my watchlist

Not a member yet?

Sign up now for a free account